资源描述:
《To exploit the tumor microenvironment. Passive and active tumor targeting of》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、JournalofControlledRelease148(2010)135–146ContentslistsavailableatScienceDirectJournalofControlledReleasejournalhomepage:www.elsevier.com/locate/jconrelReviewToexploitthetumormicroenvironment:Passiveandactivetumortargetingofnanocarriersforanti-cancerdrugdeliver
2、yaba,⁎FabienneDanhier,OlivierFeron,VéroniquePréataUniversitéCatholiquedeLouvain,LouvainDrugResearchInstitute,UnitofPharmaceutics,UCL-FARG7320,AvenueE.Mounier,B-1200,Brussels,BelgiumbUniversitéCatholiquedeLouvain,PoleofPharmacologyandTherapeutics,InstituteofExpe
3、rimentalandClinicalResearch,UCL-FATH5349,AvenueE.Mounier,B-1200,Brussels,BelgiumarticleinfoabstractArticlehistory:Becauseoftheparticularcharacteristicsofthetumormicroenvironmentandtumorangiogenesis,itisReceived31May2010possibletodesigndrugdeliverysystemsthatspe
4、cificallytargetanti-cancerdrugstotumors.MostoftheAccepted10August2010conventionalchemotherapeuticagentshavepoorpharmacokineticsprofilesandaredistributednon-Availableonline24August2010specificallyinthebodyleadingtosystemictoxicityassociatedwithserioussideeffects.Th
5、erefore,thedevelopmentofdrugdeliverysystemsabletotargetthetumorsiteisbecomingarealchallengethatisKeywords:currentlyaddressed.NanomedicinecanreachtumorpassivelythroughtheleakyvasculaturesurroundingActivetargetingPassivetargetingthetumorsbytheEnhancedPermeability
6、andRetentioneffectwhereasligandsgraftedatthesurfaceofEnhancedPermeabilityandRetentioneffectnanocarriersallowactivetargetingbybindingtothereceptorsoverexpressedbycancercellsorangiogenicNanocarriersendothelialcells.Thisreviewisdividedintotwoparts:thefirstonedescri
7、besthetumormicroenvironmentandthesecondonefocusesontheexploitationandtheunderstandingofthesecharacteristicstodesignnewdrugdeliverysystemstargetingthetumor.Deliveryofconventionalchemotherapeuticanti-cancerdrugsismainlydiscussed.©2010ElsevierB.V.Allrightsreserved
8、.Contents1.Introduction..............................................................1352.Tumormicroenvironment.......................................................1362.1.